IMMUNOMODULATING, METABOLIC AND CARDIOPROTECTIVE EFFECTS OF AT1-ANGIOTENSIN RECEPTORS BLOCKER LOSARTAN IN PATIENTS WITH CORONARY HEART DISEASE AND TYPE 2 DIABETES MELLITUS

被引：0
|
作者：
Teplyakov, A. T. [1 ]
Mayanskaya, S. D. [1 ]
Bolotskaya, L. A. [1 ]
Vdovina, T. V. [1 ]
Stepacheva, T. A. [1 ]
Kuznetsova, A., V [1 ]
Lukinov, A., V [1 ]
Derbeneva, N., V [1 ]
Frants, M., V [1 ]
Shilov, S. N. [1 ]
机构：
[1] Russian Acad Med Sci, State Univ, Sci Res Inst Cardiol, Tomsk Sci Ctr,Siberian Branch, Moscow 109801, Russia
来源：
TERAPEVTICHESKII ARKHIV | 2009年 / 81卷 / 03期
关键词：
RANDOMIZED-TRIAL; CLINICAL STATUS; MORTALITY; ENALAPRIL; INTERVENTION; HYPERTENSION; IRBESARTAN; CAPTOPRIL; SURVIVAL; MODERATE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：62 / 69
页数：8
相关论文
共 50 条
  • [1] Losartan -: The blocker of AT1-angiotensin receptors:: Novel direction in the treatment of chronic heart failure
    Sidorenko, BA
    Preobrazhensky, DV
    KARDIOLOGIYA, 1997, 37 (10) : 84 - 87
  • [2] The effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease
    Hoseini, Asma
    Namazi, Gholamreza
    Farrokhian, Alireza
    Reiner, Zeljko
    Aghadavod, Esmat
    Bahmani, Fereshteh
    Asemi, Zatollah
    FOOD & FUNCTION, 2019, 10 (09) : 6042 - 6051
  • [3] The effects of combined magnesium and zinc supplementation on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease
    Hamedifard, Zahra
    Farrokhian, Alireza
    Reiner, Zeljko
    Bahmani, Fereshteh
    Asemi, Zatollah
    Ghotbi, Maryam
    Taghizadeh, Mohsen
    LIPIDS IN HEALTH AND DISEASE, 2020, 19 (01)
  • [4] The effects of combined magnesium and zinc supplementation on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease
    Zahra Hamedifard
    Alireza Farrokhian
    Željko Reiner
    Fereshteh Bahmani
    Zatollah Asemi
    Maryam Ghotbi
    Mohsen Taghizadeh
    Lipids in Health and Disease, 19
  • [5] Smoking and coronary heart disease in patients with type 2 diabetes mellitus
    Kawada, Tomoyuki
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 133 : 211 - 211
  • [6] The Influences of Chromium Supplementation on Metabolic Status in Patients with Type 2 Diabetes Mellitus and Coronary Heart Disease
    Farrokhian, Alireza
    Mahmoodian, Mina
    Bahmani, Fereshteh
    Amirani, Elaheh
    Shafabakhsh, Rana
    Asemi, Zatollah
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2020, 194 (02) : 313 - 320
  • [7] The Influences of Chromium Supplementation on Metabolic Status in Patients with Type 2 Diabetes Mellitus and Coronary Heart Disease
    Alireza Farrokhian
    Mina Mahmoodian
    Fereshteh Bahmani
    Elaheh Amirani
    Rana Shafabakhsh
    Zatollah Asemi
    Biological Trace Element Research, 2020, 194 : 313 - 320
  • [8] Type 2 diabetes mellitus and coronary heart disease
    Brändle, M
    Amann, FW
    Salomon, F
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1999, 129 (18) : 700 - 706
  • [9] Optimisation of the management of patients with coronary heart disease and type 2 diabetes mellitus
    Wilson, SH
    Kennedy, FP
    Garratt, KN
    DRUGS & AGING, 2001, 18 (05) : 325 - 333
  • [10] Predictive nomogram for coronary heart disease in patients with type 2 diabetes mellitus
    Xiao, Shucai
    Dong, Youzheng
    Huang, Bin
    Jiang, Xinghua
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
12345